Digital Library
Close Browse articles from a journal
 
Search for with title:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             53 results found
no title author magazine year volume issue page(s) type
1 Approach in glucocorticoid-induced osteoporosis prevention: The EGEO study preliminary data Migliaccio, S.
 2009
 45 S3 p. S137-
1 p.
 article
2 Assessment of risk of osteoporosis in a population of menopausal women by OsteoRisk in Brazil Bueno, A.N.
 2009
 45 S3 p. S137-S138
2 p.
 article
3 Awareness of glucocorticoid-induced osteoporosis: Influence of gender Mazziotti, G.
 2009
 45 S3 p. S138-
1 p.
 article
4 Bisphosphonates in GIO: Novel insights in their action Moro, L.
 2009
 45 S3 p. S124-
1 p.
 article
5 Bone health in congenital adrenal hyperplasia Thorén, M.
 2009
 45 S3 p. S125-S126
2 p.
 article
6 Bone involvement in subclinical Cushing syndrome Scillitani, A.
 2009
 45 S3 p. S127-
1 p.
 article
7 Bone microarchitecture and the effects of bisphosphonate therapy Dempster, D.W.
 2009
 45 S3 p. S124-S125
2 p.
 article
8 Bone mineral density according to answer IOF's one-minute osteoporosis risk test Povoroznyuk, V.V.
 2009
 45 S3 p. S138-
1 p.
 article
9 Bone mineral density in rheumatoid arthritis: Effects of steroids and biologics and relationship with disease severity Mirone, L.
 2009
 45 S3 p. S138-S139
2 p.
 article
10 Bortezomib and osteoblast cell lineage in myeloma bone disease Zangari, M.
 2009
 45 S3 p. S123-
1 p.
 article
11 Comparison of GIO treatment with other osteoporosis treatment in the U. S. Veterans Affairs System Adler, R.A.
 2009
 45 S3 p. S139-
1 p.
 article
12 Dexamethasone affects survival of human osteoblastic cells through survivin regulation Rippo, M.R.
 2009
 45 S3 p. S139-S140
2 p.
 article
13 Does the hypothalamic–pituitary–adrenal (HPA) function influence bone loss in the early postmenopausal period? A prospective study in non-osteoporotic women Osella, G.
 2009
 45 S3 p. S140-
1 p.
 article
14 DXA and QUS in the diagnosis of GIO Gonnelli, S.
 2009
 45 S3 p. S121-S123
3 p.
 article
15 Editorial Board 2009
 45 S3 p. i-ii
nvt p.
 article
16 Effects of intermediate doses of glucocorticoids on bone turnover and circulating Dkk-1, MIF, sRANKL and OPG in patients with interstitial lung disease. A three-month longitudinal study Calzolari, G.
 2009
 45 S3 p. S140-
1 p.
 article
17 Guidelines for prevention and treatment of glucocorticoid-induced osteoporosis Compston, J.
 2009
 45 S3 p. S128-S129
2 p.
 article
18 25-Hydroxyvitamin D and 1,25-dihydroxyvitamin D levels in endogenous hypercortisolism Sanguin, F.
 2009
 45 S3 p. S145-
1 p.
 article
19 Hypovitaminosis D and prevalence of vertebral fractures in women with GIO Mazziotti, G.
 2009
 45 S3 p. S140-S141
2 p.
 article
20 Index Invited Presentations 2009
 45 S3 p. S118-S119
2 p.
 article
21 Index Oral Communications and Posters 2009
 45 S3 p. S135-S136
2 p.
 article
22 Influence of glucocorticoid replacement treatment on risk of vertebral fractures in patients with hypopituitarism Porcelli, T.
 2009
 45 S3 p. S141-
1 p.
 article
23 Inhalatory steroids and bone: The EOLO study Nuti, R.
 2009
 45 S3 p. S126-S127
2 p.
 article
24 Intermittent pamidronate therapy to treat corticosteroid induced osteoporosis Povoroznyuk, V.V.
 2009
 45 S3 p. S141-S142
2 p.
 article
25 Is there a shift of 11β-Hydroxysteroid Dehydrogenase type 1 from bone to adipose compartment during glucocorticoid excess? Camozzi, V.
 2009
 45 S3 p. S142-
1 p.
 article
26 Management of diabetes in steroid treated patients Lauro, D.
 2009
 45 S3 p. S129-
1 p.
 article
27 Management of osteoporosis in patient with rheumatoid arthritis: Strategies for improvement Md Yusof, M.Y.
 2009
 45 S3 p. S142-
1 p.
 article
28 Mechanisms of glucocorticoid-induced myopathy Thissen, J.P.
 2009
 45 S3 p. S123-S124
2 p.
 article
29 New data on teriparatide treatment Nuti, R.
 2009
 45 S3 p. S133-
1 p.
 article
30 Non-invasive assessment of bone strength in osteoporosis Bouxsein, M.L.
 2009
 45 S3 p. S124-
1 p.
 article
31 [No title] 2009
 45 S3 p. S117-
1 p.
 article
32 Osteocyte function and glucocorticoids Weinstein, R.S.
 2009
 45 S3 p. S121-
1 p.
 article
33 Oxidative stress, cell apoptosis, glucocorticoids and osteoporosis Manolagas, S.C.
 2009
 45 S3 p. S120-
1 p.
 article
34 Pathogenesis of bisphosphonate-related osteonecrosis of the jaw (ONJ): Focus on osteoimmunology Angeli, A.
 2009
 45 S3 p. S128-
1 p.
 article
35 Peculiarities of steroid osteoporosis in rheumatic patients in various age groups Haroyan, A.
 2009
 45 S3 p. S142-S143
2 p.
 article
36 RANKL inhibition as a targeted approach in the management of osteoporosis Giustina, A.
 2009
 45 S3 p. S134-
1 p.
 article
37 Regulatory networks in the control of osteoblast cell fate are influenced by glucocorticoids Lian, J.B.
 2009
 45 S3 p. S121-
1 p.
 article
38 Risedronate clinical efficacy and bisphosphonate new effectiveness data from real world clinical practice Thomas, T.
 2009
 45 S3 p. S132-S133
2 p.
 article
39 Role of Notch signaling in osteoblast differentiation and bone remodeling Canalis, E.
 2009
 45 S3 p. S120-S121
2 p.
 article
40 SATELLITE SYMPOSIUM 2009
 45 S3 p. S132-
1 p.
 article
41 Secondary osteoporosis in children Leonard, M.B.
 2009
 45 S3 p. S125-
1 p.
 article
42 Strontium ranelate and femural fracture healing during rheumatoid arthritis and osteoporosis Salvin, S.
 2009
 45 S3 p. S143-
1 p.
 article
43 Strontium ranelate in the therapeutic strategies for osteoporosis, including GIO Reginster, J.Y.
 2009
 45 S3 p. S131-
1 p.
 article
44 Teriparatide in the treatment of glucocorticoid-induced osteoporosis Bilezikian, J.P.
 2009
 45 S3 p. S131-
1 p.
 article
45 The GH–IGF-1 axis and GIO Giustina, A.
 2009
 45 S3 p. S125-
1 p.
 article
46 The glucocorticoid receptor: One gene, many proteins — New mechanisms for tissue specific anti-inflammatory actions of glucocorticoids in health and disease Cidlowski, J.A.
 2009
 45 S3 p. S120-
1 p.
 article
47 The RANKL/RANK/OPG pathway: Preclinical and clinical pharmacology with relevance to GIO Ferrari, S.
 2009
 45 S3 p. S132-
1 p.
 article
48 The system of 11β-hydroxysteroid dehydrogenases: Relevance to inflammatory bone loss Cooper, M.S.
 2009
 45 S3 p. S123-
1 p.
 article
49 Umbilical cord stroma as source of mesenchymal stem cells for bone regeneration Ciavarella, S.
 2009
 45 S3 p. S143-S144
2 p.
 article
50 Update on glucocorticoid therapy in rheumatoid arthritis Bianchi, G.
 2009
 45 S3 p. S127-S128
2 p.
 article
51 Use of teriparatide in osteoporosis due to active rheumatic diseases Salvin, S.
 2009
 45 S3 p. S144-
1 p.
 article
52 Utility of QUS assessment in COPD patients treated with GCS: The EOLO study Gonnelli, S.
 2009
 45 S3 p. S144-S145
2 p.
 article
53 Variations in cortisol sensitivity: The clinical implications of the polymorphisms in the glucocorticoid receptor gene Lamberts, S.W.J.
 2009
 45 S3 p. S129-S131
3 p.
 article
                             53 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands